HOME >> MEDICINE >> NEWS
Two studies find evidence that sunlight may have beneficial influence on cancer

Two new studies in the February 2 issue of the Journal of the National Cancer Institute have found that sun exposure may have a beneficial influence on some types of cancer. One study found an association between sun exposure and increased survival from melanoma, a potentially deadly form of skin cancer for which sun exposure is a risk factor, while the other found an association between sun exposure and a reduced risk of non-Hodgkin lymphoma.

Solar radiation is a major risk factor for melanoma. The incidence of and mortality from melanoma have been increasing over the last 50 years in all developed countries with large Caucasian populations. But as the incidence of melanoma increases, so does survival, suggesting the possibility that increasing sun exposure increases melanoma survival in addition to melanoma incidence. However, increased early detection of melanoma might also explain the increased survival.

To examine the relationship between sun exposure, early detection, and melanoma survival, Marianne Berwick, Ph.D., M.P.H., of the University of New Mexico in Albuquerque, and colleagues conducted a population-based, casecontrol study of more than 500 patients from the Connecticut Tumor Registry who had been diagnosed with melanoma in the late 1980s.

Three measures of sun exposure--sunburn, high intermittent sun exposure, and solar elastosis (an indicator of the skin's sun damage)--and a personal history of skin awareness (a measure of early detection) were all inversely associated with death from melanoma. Melanoma patients with higher levels of sun exposure or skin awareness were less likely to die. In addition, both solar elastosis and skin awareness were independently associated with increased survival from melanoma, even after adjusting for certain melanoma characteristics, such as lesion thickness and location. The authors conclude that sun exposure is associated with increased survival from melanoma.

"It would be r
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
1-Feb-2005


Page: 1 2 3

Related medicine news :

1. New studies suggest airborne SARS transmission is possible
2. New studies show mixed results on epilepsy drugs and birth defects
3. Brain imaging studies investigate pain reduction by hypnosis
4. Impact of scientific advances on drug studies and membrane research to be explored
5. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
6. Animal studies show stem cells might make biological pacemaker
7. Infants, children prefer sounds over pictures and only slowly become visually oriented, studies find
8. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
9. Gender and sex hormones affect the brains pain response and more, according to new studies
10. Analysis of tamoxifen studies reveals slight increase of stroke risk
11. Imaging studies clarify brain changes associated with language deficits in autism

Post Your Comments:
(Date:6/17/2013)... (PRWEB) June 17, 2013 The producers ... a new series of reports highlighting how sustainable farming ... of growing populations and their demand on food supplies. ... independently produced television series airing in markets around the ... the legendary Martin Sheen, who is marking the start ...
(Date:6/17/2013)... 2013 As da Vinci robot lawsuit ... country, Bernstein Liebhard LLP notes that a recent report ... of the disturbing robotic surgery complications alleged to have been ... things, the June 14th broadcast revealed that the U.S. Food ... of da Vinci patients who suffered burns, cuts and infections ...
(Date:6/17/2013)... MelanSol® All Natural Skin Care now ... US distributor for MelanSol®, has partnered with the Central ... Bank to support their efforts to feed hungry ... they receive a portion of every sale of ... Contributions will be given on sales from http://www.PureSunscreen.com ...
(Date:6/17/2013)... The Professional Center for Enhanced Performance ... open in Schertz. The center will offer ... to educational support groups. , Neurofeedback treatment is ... with athletic performance, post traumatic stress disorder, and ... LCSW, works primarily with those affected by military ...
(Date:6/17/2013)... Cleveland, Ohio (PRWEB) June 17, 2013 ... nerve damage in his legs, proved that there are ... Cleveland Marathon. While he didn’t place in the ... Volkswagen Cup. The esteemed award recognizes the individual ... event. Emerson was able to raise more than ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3Health News:All Natural Sunscreen Fights Hunger 2Health News:Professional Center for Enhanced Performance Opens in Schertz 2Health News:Cancer Survivor David Emerson Awarded Volkswagen Cup at Cleveland Marathon 2
(Date:6/17/2013)...  As the Share Repurchase Resolution has been passed at ... Corporation, plc (NYSE: ELN ) has lapsed in ... Proceedings referred to below and any consequent decision of the ... to the extent that it would have been had it ... Repurchase Resolution being passed. There can be no assurance as ...
(Date:6/17/2013)... Mass. , and SYDNEY ... Inc. (Nasdaq: HTWR ; ASX: HIN), ... support technologies that are revolutionizing the treatment of ... Food and Drug Administration (FDA) has granted conditional ... that allows HeartWare to commence enrollment in an ...
(Date:6/17/2013)... Perrigo Company (NYSE: PRGO ; ... agreement to acquire and has completed the acquisition of ... Fera Pharmaceuticals, LLC and its affiliates (Fera), a privately-held, ... pharmaceutical company. The acquired portfolio, including nine prescription ANDA ... during calendar year 2012. Terms of the transaction include ...
Breaking Medicine Technology:Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 2Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 3Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 4Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 5Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 6Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 7Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 8Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 9Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 10HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 2HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 4Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 2Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 3
Cached News: